Prime Medicine insiders buy shares, signaling favourable outlook

Prime Medicine insiders have made numerous purchases, with CEO Allan Reine buying $147k worth of shares at $1.18 each. While this purchase was made at a lower price than the current share price of $4.18, it indicates positive sentiment among insiders. Insider ownership is high at 15%, which suggests that the company is run in the interest of all shareholders. These transactions are considered favorable signals for the company.